The Board of Directors of HealthCare Global Enterprises Limited (HCG) approved significant investments into two key subsidiaries on March 30, 2026. HCG will invest up to INR 98 Crore in HCG NCHRI LLP and up to INR 155.66 Crore in Vizag Hospital to acquire an additional 34% stake. These strategic moves, funded partially by a recently approved rights issue, aim to strengthen HCG’s presence in cancer care centers and are expected to conclude by Q1 FY 2027.
HCG Board Approves Multi-Subsidiary Investment Strategy
At the Board meeting held on March 30, 2026, HealthCare Global Enterprises Limited approved material investments in two of its subsidiaries: HCG NCHRI Oncology LLP and Vizag Hospital and Cancer Research Centre Pvt Ltd. The total approved investment outlay is approximately INR 253.66 Crore.
Investment in HCG NCHRI Oncology LLP
The Board sanctioned an investment of up to INR 98 Crore in HCG NCHRI LLP, which is a wholly owned subsidiary. This investment is earmarked for enabling the pre-payment and/or repayment of certain outstanding borrowings availed by HCG NCHRI LLP.
Key Details for HCG NCHRI LLP Investment:
- Entity Business: HCG NCHRI LLP operates a 74-bedded cancer care centre in Nagpur.
- Financials (FY ended March 31, 2025): Turnover was INR 89.80 Crore, with Profit After Tax at INR 17.02 Crore.
- Consideration: The investment will be paid entirely in cash.
- Timeline: Completion is expected in Q1 FY 2027.
- Shareholding: The Company will continue to hold 100% of the capital.
Acquisition of Additional Stake in Vizag Hospital
HCG also approved an investment of up to INR 155.66 Crore for the acquisition of an additional 34% stake in Vizag Hospital, directly from its selling shareholders. This acquisition is governed by the Share Purchase Agreement originally dated June 28, 2024, as amended on October 01, 2024, and March 29, 2026.
Key Details for Vizag Hospital Acquisition:
- Entity Business: Vizag Hospital is engaged in setting up and managing cancer hospitals, cancer centres, and medical diagnostics services in Visakhapatnam.
- Financials (FY ended March 31, 2025): Turnover was INR 110.14 Crore, with Profit After Tax at INR 18.79 Crore.
- New Stake: The acquisition of 34.00% shareholding will result in HCG holding a total of 85% of the equity share capital post-acquisition.
- Consideration: The payment for the additional stake will be in the form of cash.
- Timeline: The acquisition is expected to be completed in Q1 FY 2027, subject to SPA fulfillment.
Funding Rationale
Both transactions are aligned with the stated objects of the rights issue approved by the Company on February 24, 2026. Approximately INR 98 Crore was allocated for the NCHRI LLP investment, and about INR 154.04 Crore (subject to adjustments) was allocated for the Vizag Hospital acquisition.
Source: BSE
